The Ohlthaver & List (O&L) Group is pleased to announce the appointment of Dr. Christina Swart-Opperman as a Non-Executive Director on the OLFITRA Board, effective 1 April 2025.
Dr. Swart-Opperman has been an integral part of the O&L Family since 2016, serving as Chairperson of the OLFITRA Remuneration and Nomination Committee (REMCO). Her leadership has played a pivotal role in shaping the Group’s remuneration philosophy, ensuring fairness, strategic alignment, and excellence in talent management.
A trailblazer in Namibia’s business landscape, Dr. Swart-Opperman established the country’s first Human Resource Consulting practice and made history as the first female partner at PWC. Her impact extends far beyond the corporate world - her passion for social upliftment is evident through the Christina Swart-Opperman Aids Orphan Foundation Trust, which has transformed many lives. Her PhD research on innovation and team dynamics further highlights her deep expertise in business strategy, leadership, and people development.
She now joins the esteemed OLFITRA Board, which includes:
Executive Directors: Executive Chairman and Chairperson of the OLFITRA Board, Sven Thieme; Chief Operations Officer, Wynand Oosthuizen; Chief Experience Officer, Franziska Rüeck; Chief Human Capital Officer, Terence Makari; Chief Financial Officer, Theresa Weitz; and, Corporate Affairs Manager, Gideon Shilongo.
Non-Executive Directors: Günther Hanke, Berthold Mukuahima, Hans-Harald Müseler, and Peter Grüttemeyer.
Sven Thieme, O&L Group Executive Chairman and Chairperson of the OLFITRA Board of Directors, says: “Dr. Swart-Opperman’s appointment is a testament to O&L’s commitment to strong leadership, sustainable business practices, and purpose-driven stakeholder engagement. We are confident that her wealth of knowledge, experience, and passion will further strengthen our O&L Persona characteristics of being Authentic, Caring, and Passionate."
“We warmly congratulate Dr. Swart-Opperman on this well-deserved appointment and look forward to her continued impact within the O&L family”, concluded Thieme.
